We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Antimalarial Compound Improves Forensics of Bloodstains

By LabMedica International staff writers
Posted on 12 Jun 2017
Forensic investigators often use a luminol chemiluminescence test to detect latent bloodstains at crime scenes. More...
Now, researchers have found that combining luminol with the antimalarial drug artemisinin, a natural peroxide, reduces the risk of false positives compared to the traditional method that mainly uses hydrogen peroxide or sodium perborate as coreactants. They also obtained test results using a smartphone, which could provide highly accurate on-scene analyses.

Luminol is often combined with hydrogen peroxide to react with the heme groups in blood, producing the blue chemiluminescent glow. This allows crime scene technicians to detect blood on surfaces. While this test has proven beneficial in numerous criminal investigations, false positives due to interferences from biomolecules and metal ions, as well as from the breakdown products of hydrogen peroxide, can occur.

In an effort to minimize erroneous identifications, Prof. Guobao Xu of ChangChun Institute of Applied Chemistry, Chinese Academy of Sciences (Changchun, Jilin, China) and colleagues investigated the use of artemisinin with luminol as artemisinin is more structurally sound and more resistant to interferences than hydrogen peroxide.

The researchers showed that the luminol-artemisinin combination is more selective than luminol-hydrogen peroxide, resulting in fewer false positives when challenged with components of bleaches and disinfectants, which criminals often use to cover up a misdeed. The method could distinguish blood from coffee, tea, and brown sugar stains.

The study, by Gao W et al, was published May 11, 2017, in the journal Analytical Chemistry.

Related Links:
ChangChun Institute of Applied Chemistry, Chinese Academy of Sciences


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

Screening After Pneumococcal Disease May Reveal Undiagnosed Blood Cancer or Immune Disorders

Severe pneumococcal disease requiring hospitalization often presents as pneumonia, particularly in older adults and people with cancer or compromised immune function. Because M protein testing and antibody... Read more

Microbiology

view channel
Image Credit: 123RF

FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample

Respiratory tract infections can be difficult to distinguish at presentation because many cause overlapping, nonspecific symptoms and are initially grouped as influenza-like illnesses. Causes span a range... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.